Bandhan Bank Management Change

Bandhan Bank Employee Stock Options

Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.

Bandhan Bank Earnings Call Transcript: Key Takeaways

Bandhan Bank is pivoting from its MFI roots toward a universal banking model, with non-EEB growth and secured assets stabilizing the balance sheet despite CASA pressure and transitionary headwinds in housing.

Call

Guides 14% growth

Bandhan Bank Investor Presentation: Key Takeaways

Q2FY27: PAT ₹6.2bn (+23.9% QoQ), NII ₹29.6bn (+14.4% YoY), operating profit ₹15.6bn (+18.8% YoY), NIM 6.1%, GNPA 3.1%. Secured mix rose to 57.3%.

Bandhan Bank Q2 FY27 Results: Net Profit ₹621.8 Cr, Up 455.7% YoY

Bandhan Bank Ltd reported revenue from operations of ₹5,754 Cr (+7.5% YoY) and net profit of ₹621.8 Cr (+455.7% YoY) for Q2 FY27.

Key figure

Net profit ₹621.8 Cr · +455.7% YoY

Bandhan Bank Price Movement Clarification

Bandhan Bank denies a Moneycontrol report linking it to First Abu Dhabi Bank acquisition talks, stating the reference in the article is factually incorrect.

Bandhan Bank Other Announcement

Bandhan Bank Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by regulatory compliance.

Travel Food Services Management Change

Travel Food Services appointed Avinash Yogeshwar as Senior Managerial Personnel, effective 29 October 2026. It is a senior leadership change with no financial impact.

Swan Defence and Heavy Industries Management Change

Swan Defence designated three existing employees as Senior Management Personnel effective 29 October 2026, following organisational restructuring. The move reflects leadership reorganisation, not new capital or contracts.

Prima Innovation Management Change

Prima Innovation Limited reported the resignation of Non-Executive Director Dilip M. Parekh, effective 29-10-2026, citing personal reasons. The exit is a board-level change investors should note.

Strides Pharma Science Management Change

Strides Pharma's board appointed Biren Gabhawala as Non-Executive Independent Director effective November 1, 2026, for five years. He is a Chartered Accountant with extensive audit and listed-company board experience.

Execution

Five-year term effective November 1, 2026

Srivasavi Adhesive Tapes Management Change

Srivasavi Adhesive Tapes appointed Ms. Venugopal as Chief Financial Officer effective 29 October 2026. She holds an MBA in Finance with seven years of finance experience.

Restaurant Brands Asia Management Change

Restaurant Brands Asia appointed nine persons on October 29, 2026, including two directors, a CEO and senior management heads. Shivkumar Dega joins as a non-executive independent director.